prescription-only medicines

Views & Analysis

On 28 September 2022, the international and European self-regulatory bodies for the research-based pharmaceutical industry (I

Oncology

Roi Raz, CEO of ReBio Pharma, discusses injectable, bioresorbable sustained release delivery for ophthalmic therapeutics at LSX 2026.

Sales & Marketing

As AI continues to reshape the healthcare landscape, pharma teams are beginning to leverage synthetic personas.